General
Preferred name
PROPAFENONE
Synonyms
PROPAFENONE HYDROCHLORIDE ()
Propafenone (D7 hydrochloride) ()
SA-79 (D7 hydrochloride) ()
Rythmol ()
Propafenonum ()
SA-79 ()
SA-79 (hydrochloride) ()
Propafenone (hydrochloride) ()
Propafenone HCl ()
Propafenone (hydrochloride) ()
Propafenone-d5 (hydrochloride) ()
NSC-758640 ()
Rythmol Sr ()
Arythmol ()
Rytmonorm ()
Propafenon hexal ()
GNF-Pf-4594 ()
P&D ID
PD002872
CAS
34183-22-7
54063-53-5
107300-59-4
163858-56-8
1346605-05-7
Tags
available
natural product
drug
Approved by
FDA
First approval
1989
Drug indication
Tachyarrhythmias
Cardiac Depressant (anti-arrhythmic)
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PHARMACODYNAMICS
Propafenone is a Class 1C antiarrhythmic drug with local anesthetic effects, and a direct stabilizing action on myocardial membranes. It is used in the treatment of atrial and ventricular arrhythmias. It acts by inhibiting sodium channels to restrict the entry of sodium into cardiac cells resulting in reduced excitation. Propafenone has local anesthetic activity approximately equal to procaine.
DESCRIPTION
Marketed formulations may contain propafenone hydrochloride (PubChem CID 36708).
(GtoPdb)
DESCRIPTION
Blocks hKv1.5 and ATP-sensitive K+ channels; beta-adrenoceptor antagonist
(LOPAC library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
1
Compound Sets
29
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Other bioactive compounds
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
66
Properties
(calculated by RDKit )
Molecular Weight
341.2
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
11
Ring Count
2
Aromatic Ring Count
2
cLogP
3.24
TPSA
58.56
Fraction CSP3
0.38
Chiral centers
1.0
Largest ring
6.0
QED
0.49
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
hKv1.5
Target
Sodium Channel
MRP1
Potassium Channel
Adrenergic Receptor
Adrenergic Receptor,Sodium Channel
Pathway
Membrane Transporter/Ion Channel
Immunology/Inflammation
GPCR/G protein
Neuronal Signaling
Therapeutic Class
Antiarrhythmic Agents
VGSC Target
Nav1.5
Source data